The cholera outbreak in northern Iraq continues to be a major threat to public health in the region with over 3.3 million people presumed to be exposed to the risk of an epidemic, according to an update by the United Nations health agency.
As many as one in four people in westernized countries experience pain or discomfort in their upper abdomen, and physicians have almost nothing to offer except anti-acid medicines, which usually don’t work. Now, in a small but novel study, researchers have found evidence that an abnormal amount of inflammatory cells populates the upper intestine of affected individuals, which suggests a fresh way of understanding the common complaint.
On September_4, 2007 Mr. Dennis Wasylyszyn, an employee of Aberdeen Farm Market in Coldstream, B.C., pled guilty in provincial court to one count of violating s.4(e) of the Food and Drugs Act by selling an article of food which was manufactured or prepared under unsanitary conditions. Mr. Wasylyszyn was fined $2000 for this violation.
A scientist at Leeds whose research is challenging conventional thinking on how the cholesterol-reducing drugs statins benefit cardiac patients, has secured funding to further investigate her findings.
An ancient mechanism for coping with environmental stresses, including heat and toxic exposures, also helps cancerous tumors survive, reveals a new report in the Sept. 21, 2007, issue of Cell, a publication of Cell Press. The findings could lead to a new way to treat cancer and may also have implications for the treatment of neurodegenerative and other diseases, according to the researchers.
It may seem that therapy and law do not share a common bond, but one University of Arizona law professor is making that connection by developing a body of knowledge to prove that legal proceedings can be calming and supportive.
Even in challenging cases, CT angiography (CTA) offers an accurate and rapid diagnosis for blunt trauma victims who may have aortic or great vessel injury negating the need for more invasive procedures, according to a recent study conducted by radiologists at the University of Washington and the Harborview Injury Prevention and Research Center in Seattle, WA.
New research, including two studies presented this week at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD), further support the cardiovascular safety of ACTOS (pioglitazone HCI) and its benefits regarding improved blood glucose and blood lipid levels for patients with type 2 diabetes.
Immune cells from “cancer-resistant” people are to be injected into those with cancer to help fight the disease. Zheng Cui at Wake Forest University of Medicine in Winston-Salem, North Carolina, and his colleagues have received permission from the US Food and Drug Administration (FDA) to screen people for their ability to ward off cancer.
An analysis of previously published studies suggests that there are approximately linear relationships of apolipoprotein E genotypes with lipid levels and with coronary risk, according to a review article in the Sept. 19 issue of JAMA.